United States · FDA National Drug Code directory

Ranitidine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
55111-131_210e3c0b-be93-aa50-550d-e383e7d5f19e
Product NDC
55111-131
Form
TABLET
Composition / generic term
Ranitidine
Labeler
Dr. Reddy's Laboratories Limited
Marketing category
ANDA
Marketing start / end (source format)
20000301
Source listing expiry
20261231

Source-listed ingredients

  • RANITIDINE HYDROCHLORIDE — 75 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (55111-131-04) / 120 TABLET in 1 BOTTLE · 55111-131-04
  • 2 BLISTER PACK in 1 CARTON (55111-131-14) / 10 TABLET in 1 BLISTER PACK · 55111-131-14
  • 1 BOTTLE in 1 CARTON (55111-131-30) / 30 TABLET in 1 BOTTLE · 55111-131-30
  • 1 BOTTLE in 1 CARTON (55111-131-37) / 160 TABLET in 1 BOTTLE · 55111-131-37
  • 1 BOTTLE in 1 CARTON (55111-131-45) / 45 TABLET in 1 BOTTLE · 55111-131-45
  • 1 BOTTLE in 1 CARTON (55111-131-60) / 60 TABLET in 1 BOTTLE · 55111-131-60
  • 1 BLISTER PACK in 1 CARTON (55111-131-79) / 10 TABLET in 1 BLISTER PACK · 55111-131-79
  • 1 BOTTLE in 1 CARTON (55111-131-80) / 80 TABLET in 1 BOTTLE · 55111-131-80
  • 3 BLISTER PACK in 1 CARTON (55111-131-81) / 10 TABLET in 1 BLISTER PACK · 55111-131-81
  • 1 BOTTLE in 1 CARTON (55111-131-90) / 90 TABLET in 1 BOTTLE · 55111-131-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →